Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma. This evidence concerns the gene HDAC1 and primary cutaneous T-cell non-Hodgkin lymphoma.